AMAL vs TMO · P/E 9.8, rev $226.5M vs P/E 24, rev $23.00B
Amalgamated Bank (AMAL) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Amalgamated Bank (AMAL) is a banks - regional company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported AMAL revenue for 2026-06-30 was $226.5M. Net income was $60.0M. AMAL currently screens at market cap $1.02B and trailing P/E 9.8.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
AMAL currently screens at market cap $1.02B and trailing P/E 9.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the AMAL and TMO stock pages for the full models.
Not investment advice.